Home » Topics » Regulatory

Regulatory
RSS

Feridex I.V. sNDA deemed not approvable by FDA

Sep. 4, 2001

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Study investigates Toprol-XL for reversal of cardiac remodeling

Sep. 4, 2001

GSK claims new adenosine A1 agonist formulations for the treatment of pain

Aug. 29, 2001

European approval granted for Ketek, Aventis' first-in-class antibiotic

Aug. 21, 2001

FDA approves Natrecor for treatment of congestive heart failure

Aug. 14, 2001

Roche receives first approval for PEGASYS

Aug. 10, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

New intraocular pressure-lowering agent introduced to Japanese market

July 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...